Neuracle Science Receives A and BBB Ratings in Technology Evaluation for KOSDAQ Listing
Newracle Science Receives High Ratings in Technology Evaluation CEO Seong Jae-young of Newracle Science announced on the 17th that the company has achieved outstanding ratings in the ‘technology evaluation’ process. The company received A and BBB ratings from two technology evaluation agencies designated by the Korea Exchange, marking a significant milestone for the company. Hailing […]
HEM Pharma Prepares for Listing on KOSDAQ Following Technical Evaluation
HEM Pharma Prepares for KOSDAQ Listing Following Successful Technical Evaluation Microbiome healthcare expert HEM Pharma, led by CEO Joseph Joseph, is gearing up for its listing on the KOSDAQ after passing the rigorous technical evaluation process. On the 1st of February, HEM Pharma announced that it had fulfilled the requirements for standard listing, thereby gaining […]
